Provided by Tiger Trade Technology Pte. Ltd.

GlaxoSmithKline PLC

50.30
+0.28500.57%
Volume:1.04M
Turnover:52.51M
Market Cap:101.73B
PE:16.08
High:50.71
Open:50.18
Low:50.06
Close:50.01
52wk High:61.70
52wk Low:39.29
Shares:2.02B
Float Shares:1.94B
Volume Ratio:0.97
T/O Rate:0.05%
Dividend:1.83
Dividend Rate:3.64%
EPS(TTM):3.13
EPS(LYR):3.74
ROE:33.38%
ROA:10.01%
PB:4.29
PE(LYR):13.46

Loading ...

Positive Report for GlaxoSmithKline (GSK) from Berenberg Bank

TIPRANKS
·
Yesterday

Sector Update: Healthcare

MT Newswires Live
·
Yesterday

Is the Shingles Vaccine the Secret to Living Longer and Delaying Dementia? Here's What the Science Says.

Dow Jones
·
Sep 15

GSK upgraded to Buy from Hold at Berenberg

TIPRANKS
·
Sep 15

GSK Doubles Down On Oncology: Buys Global Rights To Chimagen's Trispecific TCE For Up To $750 Million

Options & Short Sell
·
Sep 15

GlaxoSmithKline (GSK) Gets a Hold from RBC Capital

TIPRANKS
·
Sep 15

GSK Rises Monday, Outperforms Market

Dow Jones
·
Sep 15

European Equities Traded in the US as American Depositary Receipts Drop in Monday Trading

MT Newswires Live
·
Sep 14

Roche, GSK's Lung-Cancer Drug Candidates Show Promise in China

Dow Jones
·
Sep 14

Movement Alert|GlaxoSmithKline PLC Rises 4.07% in Regular Trading, Lung Cancer Drug Jideytro Achieves 94% Response Rate in First-Line Trial

Market Focus
·
Sep 14

Sector Update: Healthcare Stocks Rise Premarket Monday

MT Newswires Live
·
Sep 14

【US Pre-Market】US Stock Futures Fall as AI Giants Call to Slow Model Development; AI Supply Chain Tumbles, Led by Memory and Optical Sectors

TradingKey
·
Sep 14

Movement Alert|GlaxoSmithKline PLC Rises 3.32% in Pre-Market Trading, Lung Cancer Drug Jideytro Achieves 94% Response Rate in First-Line Trial

Market Focus
·
Sep 14

J.P. Morgan Reaffirms Their Sell Rating on GlaxoSmithKline (GSK)

TIPRANKS
·
Sep 14

GSK's Potential Small-Cell Lung Cancer Drug Meets Primary Endpoint in Late-Stage Trial

MT Newswires Live
·
Sep 14

Big Pharma is Pouring Billions into China's Biotechs

Dow Jones
·
Sep 14

GSK Says New Lung-Cancer Drug Shows Benefits at Earlier Stage of Treatment

Dow Jones
·
Sep 14

GSK licensor Hansoh announces ARTEMIS-008 phase III trial met primary endpoint

TIPRANKS
·
Sep 13

GSK Slides Thursday, Underperforms Market

Dow Jones
·
Sep 11

GSK announces Japan’s MHLW approved prefilled syringe presentation of Shingrix

TIPRANKS
·
Sep 10